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Abstract
OBJECTIVES: Treatment of pulmonary atresia with ventricular septal defect (PA + VSD) has evolved during recent decades, but it still
remains challenging. This study evaluated 41-year experience of outcome, survival and treatment of PA + VSD patients.
METHODS: Patient records and angiograms of 109 patients with PA + VSD born in Finland between 1970 and 2007, and treated at the
Children’s Hospital, Helsinki University Central Hospital, were retrospectively analysed in this nationwide study.
RESULTS: Of the 109 patients, 66 (61%) had simple PA + VSD without major aortopulmonary collateral arteries (MAPCAs). Although we
observed no difference in overall survival between those with or without MAPCAs, the patients without MAPCAs had better probability
to achieve repair (64 vs 28%, P < 0.0003). Only 3 patients were treated by compassionate care. Overall survival was affected by the size
of true central pulmonary arteries on the ﬁrst angiogram (P = 0.001) and whether repair was achieved (P < 0.0001). After successful
repair, the survival rate was 93% at 1 year, 91% from the second year, and functional capacity as assessed by New York Heart
Association (NYHA) I–II remained in 85% of patients alive at the end of follow-up. Palliated patients at 1, 5, 10 and 20 years of age had
Kaplan–Meier estimated survival rates of 55, 42, 34 and 20%, respectively. Patients who underwent repair attempts but were left pal-
liated with right ventricle (RV)–pulmonary artery connection and septal fenestration had better survival than the rest of the palliated
patients (P = 0.001). Further, the McGoon index improved after implementation of a systemic–pulmonary artery shunt in the overall
PA + VSD population (P < 0.0001).
CONCLUSIONS: These ﬁndings show that achievement of repair and initial size of true central pulmonary arteries affect survival of
patients with PA + VSD. Although the overall survival of patients with MAPCAs showed no difference compared with simple PA + VSD
patients, they had a higher risk of remaining palliated. However, palliative surgery may have a role in treatment of PA + VSD because the
size of pulmonary arteries increased after placement of systemic–pulmonary artery shunt. In addition, subtotal repair by a RV–pulmonary
artery connection and septal fenestration improved survival over extracardiac palliation.
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INTRODUCTION
Pulmonary atresia with ventricular septal defect (PA + VSD) has
an incidence between 4.2 and 10 per 100 000 live births [1–3].
Within this patient group, there is anatomical diversity: the size
of central pulmonary arteries varies from diminutive/absent to
reasonable, and pulmonary blood supply is derived either from
native pulmonary arteries or major aortopulmonary collateral ar-
teries (MAPCAs), or both. Unfortunately, the natural survival and
survival in the early surgical era have been dismal. Patients with
PA + VSD, with or without MAPCAs, have been described as
having less than a 50% chance of being alive at 10 years of age
[2]. PA + VSD patients with MAPCAs, instead, have had only a 40%
chance being alive at 10 years of age, and a 20% chance being
alive at the age of 30 [4].
Surgical treatment of PA + VSD aims at repair, consisting of VSD
closure and reconstruction of a connection between the right ven-
tricle (RV) and pulmonary arteries allowing antegrade pulmonary
blood ﬂow. However, problems may arise when the true pulmonary
arteries are scanty and multiple MAPCAs exist. The treatment proto-
col at our institution prefers staged repair, whereas some institutions
aim at primary repair despite anatomical factors [5]. As preparatory
palliative surgery, we perform a systemic–pulmonary artery shunt to
secure postnatal pulmonary circulation aiming at enlarging the
native, often diminutive pulmonary arteries. If MAPCAs exist, they
are either connected to pulmonary arteries (unifocalization) or
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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ligated and disconnected from the pulmonary circulation, depend-
ing on their importance to pulmonary blood supply.
Modern surgical strategies have had a positive inﬂuence on the
naturally very poor survival rate of PA + VSD [5–8]. Studies with exten-
sive follow-up demonstrating improved survival and increased rates
of surgical repair, however, are scarce [7, 9]. Further, most studies con-
cerning survival into adulthood have concentrated on only PA + VSD
patients with MAPCAs [4, 10], and the data on the MAPCAs’ effects
on the survival of PA + VSD are controversial [9, 11–13].
The present retrospective nationwide study investigated long-term
survival and factors affecting survival of PA + VSD patients, with and
without MAPCAs, born in Finland from 1970 to 2007. In addition,
the factors inﬂuencing achievement of repair were identiﬁed.
Further, we evaluated morphology and growth of central pulmonary
arteries, and source of pulmonary blood supply from angiograms.
MATERIALS ANDMETHODS
Patients
This study comprised 109 PA + VSD patients, with or without
MAPCAs, born in Finland from 1970 to 2007 and treated at the
Children’s Hospital, Helsinki University Central Hospital. The institu-
tion’s ethics committee approved the study protocol.
Since 1995, all paediatric cardiac surgery in Finland has been cen-
tralized to our hospital. Even before this, all corrective surgeries and
the vast majority of palliative surgeries for children with congenital
heart defect were performed in our hospital. All PA + VSD patients
born in Finland between 1995 and 2007—when the yearly birth rate
in Finland was on average 58 000—were included in our study.
Review of the cardiac surgical database and the medical records
found 127 patients, 18 of whom were excluded, either because the
presence of the right ventricular outﬂow tract changed their correct
diagnosis to Tetralogy of Fallot (n = 7) or because PA + VSD was asso-
ciated with other major cardiac abnormalities (n = 11), such as atrio-
ventricular septal defect, atrioventricular discordance, transposition
of the great arteries, double outlet RV, total anomalous pulmonary
venous drainage or univentricular heart. Thus, the present study
included 109 patients whose medical records, angiograms and op-
erative reports were reviewed. In the PA + VSD population of our
manuscript, antenatal diagnosis of PA + VSD was extremely rare
(n = 5) and thus insigniﬁcant for our study (Table 1). Direct RV–left
ventricle (RV/LV) systolic pressure ratio was measured at the end of
the operation (data documented for 33 patients). During follow-up
after repair, right ventricular pressure (RVP) was measured at cardiac
catheterization (data available for 15 patients), or estimate of systolic
RVP was determined by the maximal tricuspid valve regurgitation
velocity on Doppler echocardiography (data available for 18
patients). The causes and dates of death were obtained from
Table 1: Patient characteristics
Simple PA + VSD (n = 66) PA + VSD +MAPCAs (n = 43) P
Male gender, n (%) 33 (50) 26 (60) 0.28
Birth weight (kg) 2.86 ± 0.83 3.09 ± 0.73 0.15
Antenatal diagnosis, n (%) 5 (8) 0 (0) 0.07
Age at postnatal diagnosis (months) 0.94 ± 7.0 0.99 ± 2.0 0.96
Associated cardiac findings, n (%)a 27 (41) 17 (40) 0.89
Comorbidities, n (%) 24 (36) 15 (35) 0.88
22q11.2 deletion 3 (5) 9 (21) 0.01
Other genetic or significant syndromeb 14 (21) 1 (2) 0.004
Extracardiac anomalyc 7 (11) 5 (12) 0.87
Morphological characteristics
Presence of pulmonary artery confluenced, n (%) 66 (100) 31 (72) <0.0001
Source of pulmonary circulationd, n (%)
True pulmonary arteries only 66 (100)
MAPCAs only 16 (37)
True pulmonary arteries and MAPCAs 27 (63)
First available angiograme
McGoon index, median (IQR) 1.50 (1.11–1.77) 0.75 (0.09–1.09) <0.0001
TNPAI, median (IQR) 150 (87–301)
Lung segments supplied by native pulmonary arteries, mean ± SD 19.8 ± 0.9 5.4 ± 6.1 <0.0001
Lung segments supplied by MAPCAs, mean ± SD 0 11.6 ± 1.8
Hypoperfused lung segments, mean ± SD 0.3 ± 1.0 1.7 ± 2.2 0.007
Preoperative angiogram prior to repair attemptf
McGoon index, median (IQR) 1.78 (1.39–2.00) 1.41 (1.05–1.60) 0.005
Hypoperfused lung segments, mean ± SD 0.3 ± 1.1 1.8 ± 2.4 0.02
PA + VSD: pulmonary atresia with ventricular septal defect; MAPCA: major aortopulmonary collateral artery; TNPAI: total neopulmonary arterial index; IQR:
interquartile range; SD: standard deviation; VACTERL: vertebral defects, anal atresia, cardiac defects, tracheo-oesophageal fistula, renal anomalies and limb
anomalies.
aRight-sided aortic arch (n = 27), left superior vena cava (n = 7), atrial septal defect (n = 5), abnormal coronary arteries (n = 4).
bLissencephaly (n = 1), Mayer-Rokitansky-Küster-Hauser syndrome (n = 1), Mucolipidosis II (n = 1), other genetic syndromes (n = 4), Trisomy 21 (n = 2),
unconfirmed but strongly suspected other syndromes (n = 4) and VACTERL (n = 2).
cCleft palate (n = 1), clubfoot (n = 1), duodenal atresia (n = 1), oesophageal atresia (n = 1), hearing loss (n = 1), hip dislocation with acetabular dysplasia (n = 1),
polydactyly and face deformity (n = 1), testicular retention (n = 1) and urinary tract anomaly (n = 4).
dData from angiogram or operation.
en = 79 for first angiogram.
fn = 62 for preoperative angiogram prior to repair attempt.
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Statistics Finland. The last follow-up of all study patients was obtained
from their patient records and Statistics Finland through December
2011.
Angiograms
Four physicians (including two paediatric cardiologists, one paedi-
atric cardiac surgeon and one paediatric cardiology research
fellow) analysed the ﬁrst angiograms of 79 patients performed at
the age of 4.9 (0.1–14.0) months, as well as preoperative angio-
grams prior to repair attempt when available (Fig. 1). Analysis of
angiograms was either from nitrocellulose ﬁlm (n = 55), videotape
(n = 36) or from digital data (n = 28). Although angiograms at our
institution have been performed according to clinical indications,
the distribution of age at the ﬁrst angiograms showed no differ-
ence between patients with or without MAPCAs, or between
patients with or without later repair (data not shown).
The presence of pulmonary artery conﬂuence, blood ﬂow to
each lung segment and the McGoon index were evaluated from
each angiogram. In addition, from the ﬁrst angiogram a total neo-
pulmonary arterial index (TNPAI)—combined cross-sectional area
of left and right pulmonary arteries at hilar level and of MAPCAs
divided by the body surface area—was calculated for patients with
MAPCAs. We interpreted MAPCAs connecting with native pulmon-
ary arteries outside the lungs as insigniﬁcant. To calculate the
McGoon index, the combined diameter of the left and right pul-
monary arteries at hilar level was divided by the diameter of the des-
cending aorta just above the diaphragm. All viewers independently
measured the vessel sizes, and the average of these four measure-
ments was used as a single datum. Finally, we compared cross-
sectional area of the descending aorta indexed with body surface
area between patients with or without MAPCAs and conﬁrmed that
the comparison revealed no statistical difference (data not shown).
Accordingly, we deemed the McGoon index, systematically used at
our institution to describe size of central pulmonary arteries an ap-
propriate tool for the present study.
Surgical management
In our hospital surgical management aimed at repair, and a patient
always underwent repair when the McGoon index was 1.5 or
above. However, at repair a postoperative RV/LV systolic pressure
ratio up to 85% was accepted if the patient was haemodynamically
stable. Repair was typically staged consisting of a preparatory pallia-
tive procedure(s) and a later repair. Repair was deﬁned as closure of
septal defects, reconstruction of a connection between the RV and
pulmonary arteries, and elimination of extra-cardiopulmonary
blood supply. Often, as a preparatory palliative procedure, a system-
ic–pulmonary artery shunt (most often a modiﬁed Blalock–Taussig
shunt) was created as an attempt to enlarge the native central
branch pulmonary arteries. Any MAPCAs without adequate com-
munication with the native pulmonary arteries were principally
targeted for unifocalization. This was previously done through
thoracotomy, but during the last 15 years, unifocalization has been
performed through sternotomy. When echocardiogram has been
deemed sufﬁcient for evaluation of initial morphology, our treat-
ment protocol has not included primary angiograms [14].
Statistical analysis
We compared qualitative variables (n with percentages) with the
χ2 test. Continuous variables [median with interquartile range
(IQR), or mean ± standard deviation (SD), as appropriate] were
compared with the t-test, Mann–Whitney U-test or Wilcoxon
matched-pairs test, as appropriate. We estimated survival prob-
abilities with the Kaplan–Meier method and compared them by
log-rank analysis. We applied a univariable Cox proportional
hazard model for regression analyses, and signiﬁcant variables in
the univariable model were used for the multivariable Cox pro-
portional hazard model. The level of statistical signiﬁcance was set
at 0.05 for all analyses. Statistics were analysed with SPSS 21.0
(SPSS, Inc., Chicago, IL, USA).
RESULTS
Patients and morphology
From 1970 to 2007, 109 children with PA + VSD were born in
Finland and treated at the Children’s Hospital, Helsinki University
Central Hospital. The incidence of PA + VSD, which could be
determined reliably from 1995 to 2007, was 6.1 per 100 000 live
Figure 1: Flow diagram of analysed angiograms. Altogether 119 angiograms of 79 PA + VSD patients were analysed. Our treatment protocol has not included native
angiograms, especially when the echocardiogram has been deemed sufﬁcient. aTwenty-two patients had no angiogram prior to preoperative angiogram.
bPreoperative angiogram on average 0.60 ± 0.80 years prior to repair. PA + VSD: pulmonary atresia with ventricular septal defect.
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births. At the end of follow-up, 62 (57%) patients were alive with a
median follow-up time of 18.0 years (range 4.04–41.77 years). For
the overall study population, including patients who died during
the follow-up, the median follow-up time was 11.4 years (range
0.01–41.77 years). Patient characteristics and morphological data
from the angiograms are presented in Table 1.
At the primary angiogram prior to any surgery the patients with
simple PA + VSD had a 73% higher McGoon index (P = 0.0002)
and 15 more lung segments indicative of perfusion by native
pulmonary arteries (P < 0.0001) than the patients with MAPCAs.
Also, when all ﬁrst angiograms were analysed, the patients with
simple PA + VSD had a 99% higher (P < 0.0001) McGoon index
and had 84% less hypoperfused lung segments (P = 0.007). At the
preoperative angiogram prior to repair attempt, the patients with
simple PA + VSD had a 27% higher McGoon index (P = 0.005) and
84% less hypoperfused lung segments (P = 0.02) than patients with
MAPCAs. In patients receiving a systemic–pulmonary artery shunt
during the time between the two angiograms, the McGoon index
increased by 41% from 1.12 (0.76–1.47) to 1.58 (1.25–2.01)
(P < 0.0001). In the PA + VSD +MAPCAs subgroup, the McGoon
index improved by 103% from 0.77 (0.71–1.14) to 1.57 (1.23–1.68)
(P = 0.002). No such increase in the McGoon index was seen in the
6 patients who had no systemic–pulmonary artery shunt during
the time between the two angiograms (P = 0.23).
Surgical treatment
Repair was performed in 54 (50%) patients, of whom 49 (91%) had
staged repair with on average 1.4 ± 0.6 preparatory palliative
operations. Palliative treatment only was given to 55 (50%)
patients (Table 2), of whom 21 (38%) underwent a repair attempt
but were left with an open/fenestrated VSD (n = 16) or atrial septal
defect (ASD) (n = 5). Ten patients (18%) were deemed unsuitable
for repair for various reasons: 5 had no adequate response to sys-
temic–pulmonary artery shunt and poor peripheral pulmonary
blood supply including a patient destined for a heart–lung trans-
plant in the future; 3 received compassionate care only; and in 2
the extracardiac comorbidities prevented any further cardiac
surgery. Twenty-four (44%) patients, of whom 23 were palliated
with a systemic–pulmonary artery shunt with (n = 4) or without
(n = 19) MAPCA operation, died before their treatment strategy
was chosen or a previously planned repair was achieved.
The patients with simple PA + VSD successfully underwent repair
more often (P < 0.0003) and needed more seldom septal fenestra-
tion at the repair attempt (P < 0.0001) than the patients with PA +
VSD + MAPCAs (Table 2). Patients with the McGoon index at or
above 1.5 on the ﬁrst angiogram (n = 25) were all repaired. In 48
patients, the McGoon index was at or above 1.0 on the ﬁrst angio-
gram, and of these 36 (75%) were repaired. Of the 29 patients with
the McGoon index less than 1.0 on the primary angiogram, only 7
(24%) could be repaired, but their McGoon index had increased
1.1 ± 0.3 units by the time of repair.
We found that patients reaching repair had a 63% higher
McGoon index at the primary angiogram prior to any surgery
(P = 0.002). In the presence of MAPCAs, the TNPAI index on the
ﬁrst angiogram showed no signiﬁcant difference between patients
reaching repair [263 (142–594), n = 4] and receiving palliative
treatment only [133 (78–260), n = 19, P = 0.26]. Between patients
who remained palliated with RV–pulmonary artery connection
and septal fenestration and patients receiving other palliative
treatments only, no difference in the McGoon index on the ﬁrst
angiogram existed (P = 0.43). Patients born between 1970 and
1994 had their ﬁrst operation later (1.16 ± 2.05 vs 0.10 ± 0.23 years
Table 2: Operations
Simple PA + VSD
(n = 66)
PA + VSD +MAPCAs
(n = 43)
P
Repair 42 (64%) 12 (28%) 0.0003
1-stage repair 2 (3%) 3 (7%)
Staged repair 40 (61%) 9 (21%)
Preparatory proceduresa
RVOT patch 1 0
RV–pulmonary artery conduit/homograft 2 2
Systemic–pulmonary artery shunt 39 8
Pulmonary artery branch reconstruction 2 0
MAPCA unifocalization or ligation 8
Palliative treatment only 24 (36%) 31 (72%) 0.001
RV–pulmonary artery connection with septal fenestration 4 (6%) 17 (39%) <0.0001
RVOT patch 1 0
RV–pulmonary artery conduit/homograft 3 17
Other palliative procedures 20 (30%) 11 (26%) 0.83
Systemic–pulmonary artery shunt with or without pulmonary
artery branch augmentationb
19 9
MAPCA unifocalization 1
MAPCA unifocalization with RVOT reconstruction 1
Pulmonary artery valvulotomy 1 –
Unoperated – 3 (7%) 0.06
Data presented as n (%) or n.
PA + VSD: pulmonary atresia with ventricular septal defect; MAPCA: major aortopulmonary collateral artery; RVOT: right ventricular outflow tract; RV: right
ventricle.
aNumber of operations.
bOnly shunt (n = 19), with pulmonary artery branch augmentation/MAPCA ligation (n = 9).
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old, P = 0.0002) and were repaired later (4.80 ± 2.73 vs 1.41 ± 1.05
years old, P < 0.0001) than patients born between 1995 and 2007.
Table 3 presents the univariable analysis of selected factors
for achievement of repair. In multivariable analysis, later birth year
increased the probability of repair [hazard ratio (HR) 1.06, 95% con-
ﬁdence interval (CI) 1.02–1.10, P = 0.008]. In our study, the McGoon
index and number of lung segments supplied by native pulmonary
arteries at the ﬁrst angiogram, as well as the presence of MAPCAs
were interdependent factors. Thus, we excluded the latter two
factors from the second multivariable analysis. In this multivariable
analysis, only a higher McGoon index [HR 1.69, 95% CI 1.25–2.28,
P = 0.001 (per 0.5 units)] increased the probability of repair.
Overall survival of the patient population
and causes of death
The overall survival rate estimated with the Kaplan–Meier method
at 1, 5, 10, 20 and 30 years of age was 73, 66, 60, 55 and 53%, re-
spectively, and showed no difference between patients with or
without MAPCAs (P = 0.74, Fig. 2). During follow-up, 47 (43%)
patients died at the median age of 0.56 (0.08–4.60) years. Of all
deaths, 28 (60%) occurred within 30 days from cardiac surgery.
The underlying cause of death was congenital heart defect in all
patients, except in one who had mucolipidosis II. The immediate
cause of death was available for 25 patients, and only one of these
patients died from shunt embolism.
Univariable analysis of selected factors for mortality is pre-
sented in Table 3. In this univariable analysis, a higher McGoon
index at the ﬁrst angiogram and achievement of repair improved
survival. However, in multivariable analysis, achievement of repair
was the sole factor improving survival (HR 0.12, 95% CI 0.03–0.39,
P = 0.001). Accordingly, patients reaching repair had better
Kaplan–Meier estimated survival from birth than palliated patients
receiving only preparatory treatment both in simple PA + VSD
(P < 0.0001) and in PA + VSD +MAPCAs (P = 0.001) (Fig. 2). Further,
Kaplan–Meier estimated 20-year survival of the patients with a
McGoon index below 1.0 on the ﬁrst angiogram was 45% in
contrast to 76 and 88% if the McGoon index exceeded 1.0
(P = 0.02) and 1.5 (P = 0.006), respectively (Fig. 3).
Outcome after repair
After repair, the Kaplan–Meier estimated survival rate was 93% at
1 year and 91% from the second year on. Of the 54 patients re-
ceiving repair, 4 (3 with simple PA + VSD and 1 with MAPCAs)
died within 30 days from repair, and 1 with simple PA + VSD died
of iatrogenic hypoglycaemia 2 years from repair. The surviving
patients had a median of 18.6 (10.7–23.7) years of follow-up after
repair and a mean New York Heart Association (NYHA) class of
1.3 ± 0.5 at the latest follow-up visit, which showed no difference
between patients with or without MAPCAs (P = 0.37). At repair,
the invasively determined mean RV/LV systolic pressure ratio was
0.53 ± 0.18. The latest available invasively determined RV/LV sys-
tolic pressure ratio was 0.48 ± 0.16, on average 9.0 ± 6.0 years after
repair. The latest available echocardiographically estimated RV/LV
systolic pressure ratio was recorded on average 13.7 ± 6.9 years
after repair and was 0.30 ± 0.12.
After repair, 33 (61%) patients had surgery or catheter-based
reinterventions, and the Kaplan–Meier estimated rate of freedom
from reintervention at 1, 5, 10 and 20 years after repair was 86, 76,
57 and 33%, respectively. Ten patients had altogether 17 catheter
interventions, and 28 patients had surgery including 28 conduit
replacements, 7 pulmonary artery branch augmentations, 3 aortic
valve replacements and 2 residual MAPCA operations. Univariable
analysis of the selected factors for reintervention after repair is
reported in Table 4. However, in multivariable analysis, only a
perioperative RV/LV systolic pressure ratio above 50% increased
the probability of surgery or catheter-based reintervention (HR
3.86, 95% CI 1.07–13.93, P = 0.04).
Outcome of patients with palliative treatment only
Of the palliated patients, 52 had on average 2.0 ± 1.3 operations,
and 4 patients with RV–pulmonary artery connection and septal
Table 3: Univariable Cox regression analysis of selected variables for achievement of repair and mortality
Achievement of repair Mortality
HR (95% CI) P HR (95% CI) P
Demographic factors (n = 119)
Later year of birth (per year) 1.03 (1.01–1.06) 0.02 1.00 (0.97–1.03) 0.75
Birth weight (per kg) 0.99 (0.71–1.38) 0.95 0.78 (0.55–1.11) 0.17
Associated cardiac findings 0.95 (0.55–1.63) 0.85 1.19 (0.67–2.11) 0.56
22q11.2 deletion 0.53 (0.21–1.33) 0.18 0.30 (0.07–1.22) 0.09
Other genetic or significant syndrome 2.20 (1.02–4.75) 0.04 1.42 (0.66–3.05) 0.36
Presence of pulmonary artery confluence 5.59 (1.35–23.12) 0.02 0.91 (0.39–2.15) 0.83
Presence of MAPCAs 0.18 (0.09–0.35) <0.0001 1.10 (0.62–1.96) 0.74
Age at first operation (per year) 0.75 (0.60–0.94) 0.01 1.01 (0.86–1.18) 0.94
Achievement of repair 0.07 (0.03–0.17) <0.0001
Data from first angiograms (n = 79)
Number of lung segments supplied by true pulmonary arteries 1.15 (1.08–1.22) <0.0001 0.97 (0.93–1.02) 0.25
Higher McGoon index (per 0.5 units) 1.85 (1.41–2.42) 0.0001 0.60 (0.45–0.82) 0.001
Higher TNPAI index (per 10 units) 1.00 (1.00–1.01) 0.61 1.00 (1.00–1.01) 0.67
Improvement of McGoon index (per 0.5 units)a 1.04 (0.84–1.29) 0.70 1.25 (0.82–1.90) 0.30
CI: confidence interval; HR: hazard ratio; MAPCA: major aortopulmonary collateral artery; TNPAI: Total Neopulmonary Arterial index.
aData from 40 paired angiograms.
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fenestration had on average 2.3 ± 1.9 catheter-based interven-
tions. Patients receiving palliative treatment only had a Kaplan–
Meier estimated survival rate at 1, 5, 10, 20 and 30 years of age of
55, 42, 34, 20 and 15%, respectively. Of the 55 palliated patients,
24 died within 30 days from cardiac surgery, 17 patients died on
average 3.2 ± 4.8 years from the last cardiac surgery and 1 patient
not operated on died at 0.42 years of age. Survival of the palliated
patients was better if MAPCAs were present (P < 0.0001) but was
not affected by the size of MAPCAs assessed by TNPAI (P = 0.89).
At the end of follow-up, 2 (8%) patients with simple PA + VSD and
Figure 2: Comparison of survival from birth between patients with simple PA + VSD and PA + VSD +MAPCAs (A). Survival from birth in overall study population (B), in
patients with simple PA + VSD (C) and in patients with PA + VSD +MAPCAs (D). Comparisons between repaired patients, patients palliated with a RV–pulmonary
artery connection with SF and patients with other palliative treatment only. PA + VSD: pulmonary atresia with ventricular septal defect; MAPCA: major aortopulmonary
collateral artery; RV–PA: right ventricle–pulmonary artery; SF: septal fenestration; MAPCA: major aortopulmonary collateral artery.
Figure 3: Comparison of survival from birth between patients with a McGoon
index ≥1.5, ≥1.0 and <1.0 on the ﬁrst available angiogram.
Table 4: Univariable Cox regression analysis of selected
factors for surgery or catheter-based reintervention after
repair
HR (95% CI) P
Demographic factors
Birth year (per year) 1.02 (0.98–1.06) 0.46
Associated cardiac findings 0.81 (0.39–1.66) 0.56
22q11.2 deletion 1.53 (0.46–5.11) 0.49
Other genetic or significant syndrome 0.74 (0.26–2.11) 0.57
Presence of MAPCAs 1.92 (0.88–4.17) 0.10
Presence of pulmonary artery confluence 0.12 (0.02–0.58) 0.008
Perioperative RV/LV systolic pressure
at repair >50%a
2.73 (1.01–7.39) 0.04
Age at repair (per year) 0.91 (0.79–1.06) 0.24
Age at first operation (per year) 1.37 (1.08–1.75) 0.01
Anatomic data from preoperative angiograms prior to repair (n = 41)
Lung segments supplied by true
pulmonary arteries
0.92 (0.79–1.07) 0.25
McGoon index (per 0.5 units) 0.57 (0.36–0.88) 0.01
Improvement of the McGoon index
(per 0.5 units)b
1.12 (0.62–2.00) 0.71
CI: confidence interval; HR: hazard ratio; MAPCA: major
aortopulmonary collateral artery; RV/LV: right ventricle/left ventricle.
aData available for 33 patients.
bData from 22 paired angiograms.
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11 (35%) patients with MAPCAs were alive. Surviving patients had
a mean NYHA class of 1.7 ± 0.9 at the latest follow-up visit.
DISCUSSION
In this study, comprehensively representing the nationwide
patient population without a selection bias, we found that survival
of patients with PA + VSD is inﬂuenced by initial size of true
central PAs and whether repair is attained. Our results showed
that the presence of MAPCAs was insigniﬁcant for overall survival.
In addition, since central pulmonary arteries enlarge after imple-
mentation of a systemic–pulmonary artery shunt, palliative surgery
also may have an impact on survival of PA + VSD patients.
According to our study, the incidence of PA + VSD in Finland is
6.1 per 100 000 live births, which is in line with incidence rates
reported [1–3]. Our study demonstrated 10-, 20- and 30-year
overall survival rates of 60, 55 and 53%, respectively. These rates,
consistent with Dinarevic et al. [11] or only somewhat lower than
those by Amark et al. [7] with similar follow-up periods, conﬁrmed
that the modern survival rates are better than survival rates in
studies from earlier study periods [2, 4]. Although we could not
demonstrate birth year affecting survival in our series, we did ﬁnd
that later year of birth increased the probability of repair, which is
consistent with the ﬁndings of the previous study of Amark et al. [7].
In our study, the repair rate was 64% in the patients with simple
PA + VSD, compared with 28% of the patients with MAPCAs.
Furthermore, our ﬁnding—that presence of pulmonary artery con-
ﬂuence, higher McGoon index and more lung segments supplied
by true pulmonary arteries increased the probability of repair—
supports a more complex anatomy as a risk factor for remaining
palliated [12]. A previous study with follow-up to 1989 showed
lower repair rates than our study—46% in the patients with simple
PA + VSD and 16% in the patients with MAPCAs [12]. However, our
repair rates are somewhat lower than in previous reports with
follow-up to 1999 or later, which have shown repair rates of
80–87% in simple PA + VSD patients, and 40–60% in patients with
MAPCAs [7, 9, 15].We believe that this disparity may reﬂect institu-
tional differences in the selection criteria for a repair attempt.
After repair, both the early and late survival rates of our series
were acceptable and superior or comparable with previous series
with 10–32 years of follow-up [7, 9, 11, 16]. Additionally, our
patients after repair had good functional capacity, as well as rea-
sonable RV/LV systolic pressure ratios, which according to the
measurements decreased over the follow-up years. However,
repaired patients had frequent reinterventions, which were asso-
ciated with a RV/LV systolic pressure ratio of over 50% at repair,
smaller central pulmonary arteries prior to repair, lack of initial pul-
monary artery conﬂuence and later timing of the ﬁrst operation.
The patients in our study whose surgical treatment was limited
to palliative treatment only had a 20% chance of reaching the age of
20 years, which was poorer than reported earlier [9]. Our ﬁnding—
that patients who underwent a repair attempt but were left with an
RV–pulmonary artery connection and septal fenestration had
poorer survival than patients who achieved repair—supports failure
to close VSD at repair as a risk factor for mortality [9, 17, 18].
However, despite remaining in a palliated state, the latter patients
had signiﬁcantly better survival than patients remaining with extra-
cardiopulmonary blood supply. Of the palliated patients, those with
MAPCAs had better survival and underwent a repair attempt with
septal fenestration more often than patients without MAPCAs, who
were more likely to receive extracardiac procedures only. This
ﬁnding may explain why, in our study, in contrast to Cho et al. [9],
the palliated patients had better survival in the presence of
MAPCAs. Therefore, despite failure to achieve intracardiac repair,
palliative surgery aiming at establishment of an RV–pulmonary
artery connection should have a role in the treatment of PA + VSD.
In previous reports, achievement of repair has either improved or
has lacked inﬂuence on survival of patients with PA + VSD +MAPCAs
[10, 13]. In our series, both in patients without and with MAPCAs,
achievement of repair was the most signiﬁcant factor affecting sur-
vival. As the size of the native pulmonary arteries is very important
for both survival and achievement of repair, we believe that their
initial assessment is crucial. The lesser effect of MAPCAs on survival,
however, may have at least partly be related to the lower repair rate
compared with previous studies, and positive inﬂuence of MAPCAs
on the survival of palliated patients.
After palliation with a systemic–pulmonary artery shunt, native
central pulmonary arteries enlarged. This is consistent with previ-
ous studies demonstrating that even diminutive central pulmonary
arteries enlarge in response to a systemic–pulmonary artery shunt
[10, 19, 20]. Further, the timing of the ﬁrst operation, which often
was a creation of systemic–pulmonary artery shunt, changed
towards earlier during the follow-up in our study. Since delayed
creation of the systemic–pulmonary artery shunt may predispose
native diminutive pulmonary arteries to scarce blood ﬂow and in-
crease the susceptibility of pulmonary arteries to atrophy [8], the
change to an earlier improvement of ﬂow and shear stress may
have prevented stenosis and atrophy of the diminutive pulmonary
arteries. Thus, in addition to improved preoperative treatment
and centralization of all paediatric cardiac surgery in Finland to
our hospital, the advanced timing of the ﬁrst operation may have
resulted in increased probability of repair in PA + VSD patients
born in a later birth year.
With respect to central pulmonary arteries and pulmonary blood
supply, the patients with MAPCAs in our study had smaller central
pulmonary arteries with fewer lung segments supplied by native
pulmonary arteries than patients without MAPCAs at the primary
angiogram prior to any surgery. Besides, MAPCAs may have a poor
growth potential and may not support development of biologically
competent pulmonary circulation [10, 21, 22]. We found that
patients with MAPCAs had less lung segments indicative of perfu-
sion than patients without MAPCAs, which supports the ﬁnding
that MAPCAs have a tendency to stenose [10]. Since this difference
in the number of perfused lung segments occurred already in the
ﬁrst angiograms, we suggest that the competition between the
collateral-dependent and the ductal-dependent pulmonary blood
supply may affect the growth of the native pulmonary arteries
already during the foetal period. Since the presence of MAPCAs has
a signiﬁcant inﬂuence on the chance of eventual repair of
PA + VSD, it would be important to demonstrate their presence by
ultrasound examination antenatally [23].
Limitations
The long follow-up extending 41 years from 1970 is an important
merit of our study. However, in retrospective studies with exten-
sive follow-up the effect of continuously evolving conservative,
operative and interventional therapies in pre-, peri- and post-
operative care on morbidity and mortality may be difﬁcult to
analyse precisely since many factors affecting survival are interre-
lated. Inadequate diagnostics of the genetic syndromes in the
earlier era of our study obscured thorough evaluation of whether
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the 22q11.2 deletion syndrome had an effect on mortality. In our
study, 22q11.2 deletion was conﬁrmed in only 11% of the patients,
compared with up to 34% reported [24]. Although the size of the
central pulmonary arteries and the source of blood ﬂow to each
lung segment could be assessed from angiograms, the evidence of
the systemic–pulmonary artery shunt’s ability to promote growth
of intrapulmonary peripheral vessels remained undocumented
[25].
CONCLUSIONS
In the present retrospective study extending from 1970 to 2011,
the initial size of true central pulmonary arteries signiﬁcantly
affected the probability of repair and, together with eventual
repair, inﬂuenced the survival of PA + VSD. In our experience,
staged repair yields excellent survival with low operative mortality
and good functional capacity. Palliative surgery remains an im-
portant treatment option of PA + VSD, since after the systemic–
pulmonary artery shunt the size of pulmonary arteries increased,
and patients palliated with an RV–pulmonary artery connection
despite shunting at the septal level had better survival than the
rest of the palliated patients. Pathobiology has a role in antenatal
development of the pulmonary arteries and survival of PA + VSD
patients. Therefore, careful evaluation of the source of pulmonary
circulation, the size of pulmonary arteries, medical counselling of
the parents and centralization of invasive care of this challenging
patient group is crucial to improving outcomes.
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